Hybrid coronary revascularization was associated with similar mortality but lower repeat revascularization rates in the LAD artery compared to PCI (aHR 0.51; 95% CI 0.34-0.77).
Cohort
Yes
Hazard Ratio: 0.51 (95% CI 0.34–0.77)
OBJECTIVE: Hybrid coronary revascularization (HCR) combines a minimally invasive surgical approach to the left anterior descending (LAD) artery with percutaneous coronary intervention (PCI) for non-LAD diseased coronary arteries. It is associated with shorter hospital lengths of stay and recovery times than conventional coronary artery bypass surgery, but there is little information comparing it to isolated PCI for multivessel disease. Our objective is to compare long-term outcomes of HCR and PCI for patients with multivessel disease. METHODS: This cohort study used data from New York's cardiac surgery and PCI registries in 2010-2016 to examine mortality and repeat revascularization rates for patients with multivessel coronary artery disease who underwent HCR and PCI. Cox proportional hazards methods were used to reduce selection bias. Patients were followed for a median of four years. RESULTS: . 83.59%, aHR = 0.51 (95% CI: 0.34-0.77)). CONCLUSIONS: For patients with multi-vessel coronary artery disease, HCR is rarely performed. There are no differences in mortality rates after four years, but HCR is associated with lower repeat revascularization rates in the LAD artery, presumably due to better longevity in left arterial mammary grafts.
Hannan et al. (Sun,) conducted a cohort in multivessel coronary artery disease. Hybrid coronary revascularization (HCR) vs. percutaneous coronary interventions (PCI) was evaluated on mortality and repeat revascularization rates (aHR 0.51, 95% CI 0.34-0.77). Hybrid coronary revascularization was associated with similar mortality but lower repeat revascularization rates in the LAD artery compared to PCI (aHR 0.51; 95% CI 0.34-0.77).